Is PhD in Economics, University of California, Berkeley; MSc in Economics, London School of Economics) is an Economist at RAND. Her work, funded by NIH and other federal agencies, lies at the intersection of economics and public health. She largely focuses on studying the socio-economic determinants of and behavioral risk factors for obesity and related chronic diseases across lifespan, as well as how fiscal and other policies can modify behavior to mitigate or manage them. Most of her time is currently spent examining the role of sugar-sweetened beverage policies in obesity among Mexican teens; studying the addictive nature of sugar and long-term health impact of early sugar-rich diet in the UK; assessing the long-term value of bariatric surgery among adults with obesity and diabetes in the US; and evaluating the impact of mobile health tools in management of patients with chronic diseases in Chile. Her other work studies how infections affect cognitive decline among the elderly and evaluates the life-burden of early cognitive decline. Previously, she led analyses studying the role of insurance in medication adherence among chronically ill patients, and described how prices of foods rich in sugar contributed to a significant rise of obesity and chronic disease in Mexico over the past two decades. Dr. Gracner’s work has been published in peer reviewed journals and has earned recognition through the Juan Luis Londoño Prize, awarded for best work presented on social policy by a young researcher by the Latin American and Caribbean Economic Association.